Vericel Corporation ( VCEL) - Key Metrics
VCEL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.84 | $0.46 | $0.30 | $0.02 |
| 2025Q3 | $1.34 | $0.10 | $0.44 | $0.39 |
| 2025Q2 | $1.26 | -$0.01 | $0.16 | $0.45 |
| 2025Q1 | $1.05 | -$0.23 | $0.13 | -$0.15 |
VCEL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 19.59 |
| 2025Q3 | ? | 78.29 |
| 2025Q2 | ? | -968.88 |
| 2025Q1 | ? | -49.50 |
VCEL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.93% | ? |
| 2025Q4 | 0.04% | ? |
| 2025Q3 | 1.22% | ? |
| 2025Q2 | 1.05% | ? |
| 2025Q1 | -0.34% | ? |
VCEL
Price: $38.29
52 week price:
Earnings Per Share: 0.43 USD
P/E Ratio: 76.56
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 122353
Ebitda: -4.7 millionMarket Capitalization: 1.8 billion